Second, methods to combine therapeutic approaches, including signal transduction inhibitors, radiation or chemotherapy, should be sought earlier in development. As the PI3K pathway can mediate ...

A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...

A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated immune ...

Innovations in therapeutic strategies, coupled with a deeper understanding of breast cancer biology, will be essential for advancing personalized ...

Patients with treated, PI3K-mutated early CRC had a 50-60% ... "This is the first trial to show that mutations in this specific signaling pathway, beyond the PIK3CA mutations, predict aspirin ...

The main goal of our laboratory is the identification and characterization of signal transduction pathways that cause the dysregulation of growth and inhibition of apoptosis that characterize advanced ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner. Many ...